Case-report: Cladribine and alemtuzumab haematological treatment of chronic lymphatic leukemia and stabilizing effect on secondary-progressive multiple sclerosis

被引：0
|
作者：
Havrdova, Eva [1 ,2 ]
Krasulova, Eva [1 ,2 ]
Kozak, Tomas [3 ]
Cerna, Olga [3 ]
机构：
[1] Charles Univ Prague, Prague, Czech Republic
[2] Gen Teaching Hosp, Prague, Czech Republic
[3] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2008年 / 203卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [31] Reduction Of Risk Of Secondary Progressive Multiple Sclerosis Within Two Years Of Treatment With Cladribine Tablets: An Analysis Of The CLARITY Study
    Vermersch, P.
    Giovannoni, G.
    Soelberg-Sorensen, P.
    Rammohan, K.
    Cook, S.
    Keller, B.
    Roy, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 67 - 68
  • [32] DEMYELINATING DISEASE OF BRAIN IN CHRONIC LYMPHATIC LEUKEMIA - OCCURRENCE OF A CASE IN HUSBAND OF A PATIENT WITH MULTIPLE SCLEROSIS
    SIBLEY, WA
    WEISBERGER, AS
    ARCHIVES OF NEUROLOGY, 1961, 5 (03) : 300 - &
  • [33] Reduction of risk of secondary progressive multiple sclerosis within two years of treatment with cladribine tablets: An analysis of the clarity study
    Vermersch, P.
    Giovannoni, G.
    Soelberg-Sorensen, P.
    Rammohan, K.
    Cook, S.
    Keller, B.
    Roy, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [34] Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients
    Jamroz-Wisniewska, Anna
    Beltowski, Jerzy
    Wojcicka, Grazyna
    Bartosik-Psujek, Halina
    Rejdak, Konrad
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [35] LITHIUM IN TREATMENT OF A MANIC PATIENT WITH MULTIPLE-SCLEROSIS - CASE-REPORT
    KEMP, K
    LION, JR
    MAGRAM, G
    DISEASES OF THE NERVOUS SYSTEM, 1977, 38 (03): : 210 - 211
  • [36] Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature
    Maniscalco, G. T.
    Cerillo, I.
    Servillo, G.
    Napolitano, M.
    Guarcello, G.
    Abate, V.
    Improta, G.
    Florio, C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 175 : 134 - 136
  • [37] Natural interferon-β treatment of relapsing-remitting and secondary-progressive multiple sclerosis patients.: A two-year study
    Patti, F
    L'Episcopo, MR
    Cataldi, ML
    Reggio, A
    ACTA NEUROLOGICA SCANDINAVICA, 1999, 100 (05): : 283 - 289
  • [38] Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature
    Zimmermann, Julian
    Buhl, Timo
    Mueller, Marcus
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [39] Alemtuzumab/fingolimod/methylprednisoloneRebound effect in the form of multiple sclerosis relapse and lack of efficacy: case report
    Reactions Weekly, 2024, 2024 (1) : 26 - 26
  • [40] Lenalidomide induced secondary Acute Lymphoblastic Leukemia in a Multiple Myeloma patient: A case-report
    Khan, Saqib Raza
    Tariq, Muhammad
    Fayyaz, Sidra Malik
    Soomar, Salman Muhammad
    Moosajee, Munira
    LEUKEMIA RESEARCH REPORTS, 2022, 17
12345